Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders
The development of new treatments for substance use disorders requires identification of targetable molecular mechanisms. Pathology in glutamatergic neurotransmission system in brain reward circuitry has been implicated in relapse to multiple classes of drugs. Glutamate transporter 1 (GLT-1) crucial...
Saved in:
Published in | CNS & neurological disorders drug targets Vol. 14; no. 6; p. 745 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United Arab Emirates
01.01.2015
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!